Editions

Climate & Energy

India blends 20% ethanol into every litre of petrol — and drivers are pushing back →

A national mandate to mix ethanol into fuel now covers every pump in India. The state gains — less imported oil, money to farmers — but the small daily cost lands on drivers who never chose it. Plus: Britain's green power stuck between approval and the grid, and the US EV moment slipping away.

Personal Money

Why a loss and a gain of the same size don't cancel out →

Lose 30% and you need a 43% gain to get back to even — not 30%. The percentages that describe your money quietly measure against a moving base, and the deeper you fall the steeper the climb back.

Biotech & Longevity

The third company to crack an "undruggable" cancer target just beat the two that got there first →

Roche's late-arriving lung-cancer drug outperformed Amgen's and Bristol Myers Squibb's in a head-to-head trial — the week's clearest lesson that being first proves a thing is possible, but rarely means you keep the prize.

Mind & Body

How your gut talks to your brain — a second nervous system that mostly reports up, not down →

Your gut runs a nervous system of its own, sends far more signals up to the brain than it takes down, and makes most of your body's serotonin. The mechanism is real. The supplement that fixes your mood is mostly not.

Finance News

'Trump accounts' go live: every eligible newborn gets $1,000 — and Wall Street gets a customer for life →

The US launched federally-seeded investment accounts for children, defaulting deposits into an S&P 500 fund. Plus: Trump allies renew their push to remake the Fed, Uber freezes a European expansion to chase a takeover, and the diamond market keeps sliding.

Information Technology

The £30bn AI datacentre Britain announced was mostly a number nobody had committed →

A Guardian investigation finds two-thirds of the "£30bn" Stargate UK deal was hypothetical — and OpenAI never visited the key site. Plus Europe's sovereign-tech push and Alibaba banning Claude Code.

World News

Two enemies who hate each other attack Mali together — and its army is running out of ground →

A Tuareg separatist group and an al-Qaeda affiliate, whose goals are opposite, struck Mali's army in five towns on the same morning. Plus a besieged Sudanese city under drone fire, Ukraine's strikes deep inside Russia, and a Peru election settled by 50,000 votes.

Sports

A lacrosse league just raised $100m like a tech startup — and that's the real story in sport this week →

The Premier Lacrosse League closed a $100m funding round led by a private-equity firm and a billionaire, while football clubs broke transfer records and the NBA found its salary cap floating on a shrinking revenue stream. Different sports, one thread: outside money is pouring in, and it comes with an appetite it needs fed.

Cybersecurity

An AI agent ran a whole ransomware attack by itself — reading the room and improvising as it went →

A criminal pointed an AI agent at a hacked server and let it work. It hunted for secrets, moved between machines, and locked up the data — reasoning in plain English at each step, with no human driving.

Food & Farming

The world's biggest chocolate makers are quietly building a Plan B — one with less cocoa in it →

Record cocoa prices have pushed Mars, Nestlé, Lindt and Barry Callebaut from defending cocoa to replacing it — with fermented sunflower seed, lab-grown cells, and reformulated recipes. Plus a $3.3M egg price-fixing settlement, mounting baby-formula recalls, and a 650,000-bag chip recall.

Gaming

The people making the biggest game ever ask for a union — five months before it can't afford them to strike →

Rockstar developers requested union recognition ahead of GTA VI's November launch, a game expected to earn Take-Two around $8bn. The timing is the story: workers hold the most leverage in the narrow window before the release the studio can't delay.

Climate & Energy

Europe's heatwave killed thousands — and most of it never looked like a disaster →

France logged more than 2,000 excess deaths in a single week as a record June heat scorched the continent; the toll arrives quietly, in hospitals and homes, not in the images we call catastrophe.

Biotech & Longevity

China clears the first CAR-T for a solid tumor — the wall cancer therapy has hit for 15 years →

A Shanghai biotech won the world's first approval for a CAR-T therapy against a solid tumor, cracking a problem that has stopped the field since 2010 — plus an AI lab that now wants to make its own drugs, a 40-year-old cancer target finally cornered, and a clue to why some brains shrug off Alzheimer's.

Personal Money

Opportunity cost — the price of anything is everything you gave up to have it →

Every choice with your money quietly pays a second price: the best thing you didn't do with the same time, cash, or effort. It never shows up on a receipt, which is exactly why it's the cost people miss.

Space

A report on why Starliner failed points at the same word twice — overconfidence →

NASA's watchdog says the Boeing Starliner crisis that stranded two astronauts came from trusting a design too much and testing it too little — while the week's other space news kept moving.

World News

Europe counts its heatwave dead — at least 3,700 gone, and the toll is still rising →

France, Belgium and the Netherlands report thousands of excess deaths from June's record heat, most of them elderly people who died at home. Meanwhile a UN "red alert" over Sudan's el-Obeid, a fresh Chinese patrol off Taiwan, and Moldova's government collapses.

Information Technology

Americans are recalling their local officials to stop AI datacenters — and the grid is already buckling →

A bipartisan revolt against datacenters spread to at least seven states last month, with residents launching recall votes over projects negotiated in secret. The same week, the biggest US grid begged 67 million people to cut power in a heatwave. Plus a ransomware crew leaks Apple's iPhone 18 Pro supplier list, and China's AI-video sector pulls in another $2.8 billion.

Mind & Body

How your body holds blood sugar steady — two hormones pushing against each other, all day, every day →

Blood sugar sits in a tight range because two pancreatic hormones pull in opposite directions at once. Understanding that tug-of-war explains what a spike means, why control fails so slowly, and why most healthy people don't need to watch it.

Finance News

Oil is drowning in its own supply — and the producers keep pumping →

A real glut is finally swamping the oil market as Hormuz reopens and OPEC+ readies another output hike. Citi sees Brent near $60 by Christmas. Meanwhile a weak US jobs number all but seals a Fed pause, and dealmakers post their best half-year in ages.

Food & Farming

The world now farms 95 billion animals — and the land to feed them is where nature loses →

A landmark report finds farmed animals up 50% in two decades, with the real pressure falling not on the animals but on the cropland and water it takes to feed them.

Gaming

A game engine that thousands of studios rely on just banned AI-written code — because volunteers can't keep up with the flood →

The open-source Godot engine will no longer accept AI-authored contributions. The problem wasn't the code — it was that generating it got cheap while checking it stayed expensive, and the checkers are unpaid.

Cybersecurity

A researcher published 30 secret flaws before telling anyone who could fix them →

A pseudonymous researcher dumped AI-found zero-day exploits for the Linux kernel, PHP, VLC and more onto GitHub — skipping the industry norm of warning the makers first. Meanwhile two freshly disclosed flaws in Cisco and Citrix gear were attacked within days, and a firewall-stealing crew started handing its stolen keys to ransomware gangs.

Climate & Energy

A heat wave forces the AI grid reckoning early →

A record heat wave pushed the biggest US grid to the edge, and the federal government ordered old fossil plants to run flat out — as regulators scramble to plan for the data-center demand still coming.

Sports

An MVP-level player is being valued as "seventh best" — because a number can't see what it can't count →

A Boston Celtics forward who finished sixth in MVP voting is being talked down in trade talks by analytics that rate him far lower. The fight is really about a deeper question every sport now faces — what happens when the measure and the thing it measures disagree.

Biotech & Longevity

The gene-editing drug that doesn't cut the gene — a muscle disease is the first test →

A new kind of therapy changes what a gene does without altering the DNA itself. Early data in three patients with a muscular dystrophy is the first human sign it works. Plus China's first solid-tumor CAR-T, and a wave of rare-disease deals.

Space

Astronomers found a third galaxy with no dark matter — and that absence is the point →

A faint dwarf galaxy called DF9 appears to hold no dark matter at all, joining two neighbours that also lack it. Plus a repair spacewalk on the station's robotic arm, a new push for satellites that skim the edge of space, and a launch called off with one second left.

Personal Money

How inflation quietly shrinks the money you're not spending →

Money left sitting still doesn't lose a single pound on paper — but each year it buys a little less. Here's the mechanism, worked in real figures, and why "prices rising slower" is not the same as prices falling.

Information Technology

The AI can't deploy itself — and the industry just admitted it →

Zuckerberg told staff Meta's AI agents haven't arrived as hoped, days after betting 8,000 jobs on them. Microsoft is spending $2.5 billion to put 6,000 humans back in the loop. The gap between what the tech can do and what companies can use it for is now the story.

Mind & Body

How your blood knows when to clot — and the built-in brakes that stop it going too far →

Clotting is a controlled emergency. Your body has to plug a leak in seconds, then stop before the clot spreads and blocks a healthy vessel. It runs both jobs at once — and getting the balance wrong in either direction is dangerous.

World News

Iran buries Ayatollah Khamenei with a week of mourning — and behind the coffins, a quiet fight over who leads next →

Iran began mass funeral rites for Supreme Leader Ali Khamenei, killed in the first hours of its war with Israel. A week of choreographed grief hides the real story: for the first time in 36 years, no single person is clearly in charge.

Finance News

The US unemployment rate fell to 4.2% — because 720,000 people stopped looking for work →

June's jobs report looked like good news on one line and bad news on every other. Hiring nearly halved, past months were revised down, and the falling jobless rate hides a shrinking workforce.

Food & Farming

California scraps 'sell by' dates — the label most people read as a deadline was never a safety test →

A new California law that took effect July 1 bans consumer-facing 'sell by' dates on packaged food, standardises the rest, and targets a simple, costly confusion: shoppers throwing out good food because they misread a manufacturer's freshness guess as a safety rule.

Sports

Betting became sport's business partner — just as it corrupted the games →

Prediction markets hit $24 billion a month and FIFA signed one as a World Cup partner, while NBA players were charged with rigging bets and a quarterback was banned from two leagues.

Cybersecurity

81 million tries, 78 wins — how a brute-force attack walked past modern login defenses →

An automated campaign made 81 million login guesses against Microsoft cloud accounts and broke into 78 of them, many protected by policies that a forgotten legacy login path simply ignored.

Gaming

A California bill to keep games playable dies — killed less by 'no' votes than by senators who said nothing →

The Protect Our Games Act had more yes votes than no votes in committee. Four abstentions stopped it anyway, the same week Sony set a date to end game discs and shut its old stores.

Biotech & Longevity

The FDA delays a rare-epilepsy drug three months — and analysts blame last year's staff cuts →

A finished drug application sits in a longer queue, as the agency that reviews it runs shorter on people. Plus a gene therapy chief steps down, and a busy week of new results piling up behind them.